Overview
Neurotech Pharmaceuticals is a biotechnology company developing sight saving therapies for retinal diseases. We are ophthalmic scientists, engineers, technologists, and clinicians – all working together, inventing new treatments against blindness. Our patented core technology platform, Encapsulated Cell Technology (ECT), is a genetically engineered implant that enables the continuous delivery of protein drugs directly into the vitreous of the eye. The living ECT implants continuously treat diseased retinas for over 2 years.